Primerica Q2 revenue rises on strong client demand, favorable equity markets
Primerica Q2 revenue rises on strong client demand, favorable equity markets
Overview
U.S. financial services distributor's Q2 adjusted revenue rose 8% but slightly missed analyst expectations
Adjusted EPS for Q2 increased 17%, beating analyst expectations
Company repurchased $135 mln of common stock during the quarter
Outlook
Company did not provide specific guidance or outlook for future quarters or the full year
Result Drivers
INVESTMENT SALES GROWTH - Record investment sales and higher client asset values driven by strong client demand and favorable equity markets
TERM LIFE STABILITY - Term Life business generated stable earnings and predictable cash flow due to large in-force policy block
LOWER NEW POLICY ISSUANCE - Fewer new life insurance policies issued and lower pre-tax income in Term Life segment
Company press release: ID:nBwb84xDGa
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Adjusted Revenue | Slight Miss* | $863 mln | $870.61 mln (4 Analysts) |
Q2 Adjusted EPS | Beat | $6.41 | $6.03 (8 Analysts) |
Q2 EPS |
| $6.45 |
|
Q2 Net Income |
| $202 mln |
|
Q2 Adjusted operating income |
| $201 mln |
|
Q2 ROE |
| 32.10% |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for Primerica, Inc. is $309.00, about 2.9% below its August 4 closing price of $318.15
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago
Reuters Recommended Reads
Aug 4 - Equitable Holdings Q2 adjusted EPS beats estimates as AUM rises
Aug 3 - Jackson Financial Q2 profit jumps on favorable hedging, annuity sales growth
Aug 4 - Voya Financial Q2 profit falls on lower investment income, severance costs
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Primerica
See all newsPrimerica, Inc. reports results for the quarter ended September 30 - Earnings Summary
Financial services distributor Primerica's Q3 adjusted EPS beats on investment sales strength
Brief: Primerica Q3 Adjusted EPS USD 6.77 Vs. IBES Estimate USD 6.38
U.S. RESEARCH ROUNDUP-Accendra Health, Celestica, Sionna Therapeutics
Primerica, Inc. reports results for the quarter ended June 30 - Earnings Summary